New Two-Drug attack aims to stop liver Cancer's return
NCT ID NCT07160361
Summary
This study is testing a new combination treatment to prevent liver cancer from returning after surgery. It is for patients whose cancer has a specific high-risk feature called 'tumor budding.' Researchers will give patients two drugs: one to break down tissue barriers around the cancer and another to target the cancer cells directly, hoping this dual approach is more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.